Información del autor
Autor Spilker, Bert |
Documentos disponibles escritos por este autor (1)



TÃtulo : Guide to Drug Development : A Comprehensive Review and Assessment Tipo de documento: documento electrónico Autores: Spilker, Bert Editorial: Philadelphia [USA] : Wolters Kluwer Health Fecha de publicación: 2009 Número de páginas: 1 online resource (1295 pages) : Il.: illustrations ISBN/ISSN/DL: 978-1-4511-5725-3 Palabras clave: Drug development. Clasificación: 615/.19 Nota de contenido: bla
section 1. Introduction and overview of a company and the industry -- section 2. Basic principles, strategies, and approaches -- section 3. Corporate organization and management issues -- section 4. External corporate relationships and interactions -- section 5. Research and development organization, management, and assessments -- section 6. Clinical activities and issues -- section 7. Regulatory affairs activities and issues -- section 8. Marketing activities, issues, and interactions with medical affairs -- section 9. Functional activities and issues -- section 10. Overview of current and future development -- section 11. Case studies in clinical development, regulatory affairs, and the management of drug development.Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/164835 Guide to Drug Development : A Comprehensive Review and Assessment [documento electrónico] / Spilker, Bert . - Philadelphia [USA] : Wolters Kluwer Health, 2009 . - 1 online resource (1295 pages) : : illustrations.
ISBN : 978-1-4511-5725-3
Palabras clave: Drug development. Clasificación: 615/.19 Nota de contenido: bla
section 1. Introduction and overview of a company and the industry -- section 2. Basic principles, strategies, and approaches -- section 3. Corporate organization and management issues -- section 4. External corporate relationships and interactions -- section 5. Research and development organization, management, and assessments -- section 6. Clinical activities and issues -- section 7. Regulatory affairs activities and issues -- section 8. Marketing activities, issues, and interactions with medical affairs -- section 9. Functional activities and issues -- section 10. Overview of current and future development -- section 11. Case studies in clinical development, regulatory affairs, and the management of drug development.Enlace de acceso : https://elibro-net.biblioproxy.umanizales.edu.co/es/lc/umanizales/titulos/164835